Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-15

Clinical Trial Update: Safety of Celecoxib in Patients With Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety of celecoxib in patients with Crohn's disease was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Celecoxib (Celecoxib)

Snippet

Sponsor: University of Pittsburgh | Conditions: Crohn's Disease | Phase 4 | Status: TERMINATED | Results posted: 2016-07-15